Back to Journals » Drug Design, Development and Therapy » Volume 11

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials

Total article views   HTML views PDF downloads Totals
10,178 Dovepress* 9,296+ 937 10,233
PubMed Central* 882 289 1,171
Totals 10,178 1,226 11,404
*Since 7 November 2017

View citations on PubMed Central and Google Scholar